Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Benserazide 12.5 mg and levodopa 50 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Procaine 100 mg/mL solution for injection |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Botulism immunoglobulin 100 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
cefaklor, vattenfritt (som cefaklor) 250 milligram, tuggtablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Albiglutide 50 mg powder for solution for injection pen |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Camphor 12 microgram/mg and menthol 57 microgram/mg and methyl salicylate 63 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Trastuzumab 440 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Varicella-zoster virus antibody 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Drotrecogin alfa 5 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
3 |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Warfarin sodium 5 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
cefixim, vattenfritt (som cefixim) 40 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Somatrem 10 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
doxycyklinmonohydrat 100 milligram, munsönderfallande tablett |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Sodium cromoglicate 20 mg/actuation powder for inhalation |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Dinoprostone 10 mg prolonged-release vaginal pessary |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Sulfasalazine 30 mg/mL rectal suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 775 mg prolonged-release oral tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Amoxicillin anhydrous (as amoxicillin) 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Hexachlorophene 30 mg/mL cutaneous emulsion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
mitomycin 40 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
mitomycin 5 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Selenium sulfide 25 mg/mL cutaneous lotion |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
azitromycin, vattenfritt (som azitromycinmonohydrat) 20 milligram/milliliter, oral suspension |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Lidocaine 50 microgram/mg cutaneous patch |
Has concentration strength denominator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
tesamorelin (som tesamorelinacetat) 1 milligram/injektionsflaska, frystorkat pulver till injicerbar lösning |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Amoxicillin anhydrous (as amoxicillin) 250 mg chewable tablet |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has presentation strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
klavulansyra (som kaliumklavulanat) 1 milligram/injektionsflaska och tikarcillin (som tikarcillindinatrium) 30 milligram/injektionsflaska, pulver till injektionsvätska |
Has presentation strength numerator unit |
False |
mg |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |
cefalexin, vattenfritt (som cefalexin) 25 milligram/milliliter, oral lösning |
Has concentration strength numerator unit |
False |
mg |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 20 mg/mL oromucosal spray |
Has concentration strength numerator unit |
True |
mg |
Inferred relationship |
Some |
1 |